As of July 1, 2026, CMS (Centers for Medicare and Medicaid) began offering a program for weight loss drugs for Medicare beneficiaries called Medicare GLP-1 Bridge Program. Below is a list of FAQ’s that summarizes the program for you.
Since this article was initially published June 30, 2026, details may change. Be sure to check the CMS website for current updates. You’ll find a link to the CMS program details at the bottom of this page.
The most important aspect of this program is that you must go through your medical provider to apply. We are providing the information for you but your medical provider should be your first phone call!
What is the Medicare GLP-1 Bridge Program?
The Medicare GLP-1 Bridge Program is a temporary CMS initiative that will provide eligible Medicare beneficiaries with access to certain GLP-1 medications prescribed for weight management. The program began July 1, 2026, and is scheduled to run through December 31, 2027.
Important note: While this program is being offered to Medicare beneficiaries who have Part D prescription drug coverage, the program is not managed through your prescription drug plan, it is managed separately. Copays for this program do not count towards your Part D deductible, co-pays or out of pocket maximum.
Why is CMS creating this program?
CMS established the program to expand access to weight management treatment while gathering information that may help shape future Medicare coverage policies for weight-management medications.
When does the program start?
The Medicare GLP-1 Bridge Program launched on July 1, 2026.
Who is eligible?
Eligibility is limited to certain Medicare beneficiaries who meet CMS clinical criteria and receive approval through the program’s prior authorization process. Beneficiaries must also be enrolled in an eligible Medicare Part D plan.
People in private fee-for service plans, cost contract plans or PACE aren’t eligible for this program.
Generally:
- BMI ≥ 35 alone, or
- BMI ≥ 30 with certain chronic conditions, or
- BMI ≥ 27 with cardiovascular risk factors
Conditions that may support approval include:
- hypertension
- chronic kidney disease
- heart failure
- prior heart attack
- stroke
- peripheral artery disease
- prediabetes
Which medications are covered?
The following medications are currently eligible:
- Wegovy
- Zepbound (KwikPen formulation only)
- Foundayo
Additional eligibility requirements may apply.
What will I pay?
If you’re approved for the Medicare GLP-1 Bridge Program, you’ll pay a flat $50 copay per month for a 28- or 30-day supply of your medication — regardless of which covered drug you’re prescribed.
It is important to remember that this program operates separately from your regular Part D drug benefit, and the $50 copay works a little differently than your usual prescription costs. The $50.00 copay:
- won’t count toward your Part D deductible or out-of-pocket maximum,
- doesn’t appear on your Part D Explanation of Benefits,
- can’t be reduced through Extra Help or other low-income subsidy programs.
If you already have a discount card or manufacturer coupon, those also can’t be combined with the Bridge Program pricing.
In short — $50 is the price, with no additional discounts or credits applied on top of it.
Will these medications be covered through my Medicare Part D plan?
No. Covered GLP-1 medications for weight management will be administered through the separate Medicare GLP-1 Bridge Program rather than through a beneficiary’s Medicare Part D prescription drug plan.
How do I access the program?
The first step is to talk to your healthcare provider. They will need to submit the required documentation and prior authorization requests on behalf of eligible patients.
Do not call your Part D provider as they do not manage this program.
Is prior authorization required?
Yes. CMS requires prior authorization to confirm that beneficiaries meet the program’s clinical eligibility criteria before coverage is approved. This is done by your healthcare provider.
Are lifestyle interventions required?
Yes. The program requires participants to use GLP-1 medications in conjunction with nutrition, physical activity, and other weight-management support strategies.
What happens at the pharmacy?
Once your health care provider determines you may be a good fit for the program, they’ll send your prescription to your pharmacy just like any other medication. The pharmacy will submit the claim, and if prior authorization is still needed, they’ll notify your doctor’s office to complete it.
There’s nothing extra you need to do at this stage — once everything is approved, you’ll simply pick up your prescription and pay the $50 copay at the pharmacy counter, the same way you would for any other prescription.
Does this program cover GLP-1 medications for diabetes?
No. The Medicare GLP-1 Bridge Program is intended for weight-management treatment. GLP-1 medications prescribed for conditions already covered under Medicare, such as Type 2 diabetes, continue to follow existing Medicare coverage rules.
How long will the program last?
The program is currently scheduled to operate through December 31, 2027.
This is an important date to remember because if the program isn’t extended and you are still taking the GLP-1 through this program, you might have to start paying full price for the medication. Please discuss with your medical provider the pro’s and con’s of this decision if you are unable to afford the medication when the program ends.
What should beneficiaries do if they are interested?
Beneficiaries should speak with their healthcare provider to determine whether they may qualify and discuss whether a covered GLP-1 medication is appropriate for their treatment plan.
To learn more about the program details, refer to this information page on the CMS website Click here to see the article
If you are someone that really likes to dive deep into a topic, you might find these two articles of interest:
Please contact us if you have questions.